Opin vísindi

Fletta eftir höfundi "Mensali, Nadia"

Fletta eftir höfundi "Mensali, Nadia"

Röðun: Raða: Niðurstöður:

  • Icon
    ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma 
    Mensali, Nadia; Köksal, Hakan; Joaquina, Sandy; Wernhoff, Patrik; Casey, Nicholas P.; Romecin, Paola; Panisello, Carla; Rodriguez, René; Vimeux, Lene; Juzeniene, Asta; Myhre, Marit R.; Fåne, Anne; Ramírez, Carolina Castilla; Maggadottir, Solrun Melkorka; Duru, Adil Doganay; Georgoudaki, Anna Maria; Grad, Iwona; Maturana, Andrés Daniel; Gaudernack, Gustav; Kvalheim, Gunnar; Carcaboso, Angel M.; de Alava, Enrique; Donnadieu, Emmanuel; Bruland, Øyvind S.; Menendez, Pablo; Inderberg, Else Marit; Wälchli, Sébastien (2023-06-08)
    Osteosarcoma (OS) remains a dismal malignancy in children and young adults, with poor outcome for metastatic and recurrent disease. Immunotherapies in OS are not as promising as in some other cancer types due to intra-tumor heterogeneity and considerable ...
  • Icon
    Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer 
    Maggadóttir, Sólrún Melkorka; Dueland, Svein; Mensali, Nadia; Hamre, Hanne; Andresen, Per Arne; Myhre, Marit Renée; Juul, Hedvig V.; Bigalke, Iris; Lundby, Marianne; Hønnåshagen, Turid Kirsti; Sæbøe-Larssen, Stein; Josefsen, Dag; Hagtvedt, Trond; Wälchli, Sébastien; Kvalheim, Gunnar; Inderberg, Else Marit (2024-06-05)
    We previously demonstrated the antitumor effectiveness of transiently T cell receptor (TCR)-redirected T cells recognizing a frameshift mutation in transforming growth factor beta receptor 2. We here describe a clinical protocol using mRNA TCR-modified ...